IL-1β, TNF and IP-10 in the cerebrospinal fluid and serum are not altered in patients with idiopathic intracranial hypertension compared to controls

Clinical Endocrinology

Volumn 71, Issue 6, 2009, Pages 896-897

  Dhungana, Samish ^a   Sharrack, Basil ^a   Woodroofe, Nicola ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1BETA; LEPTIN; TUMOR NECROSIS FACTOR;

ADULT; CEREBROSPINAL FLUID; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENCEPHALOMYELITIS; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HUMAN; IDIOPATHIC INTRACRANIAL HYPERTENSION; INTRACRANIAL HYPERTENSION; LETTER; MOTOR NEURON DISEASE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SERUM;

ADULT; CHEMOKINE CXCL10; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; PSEUDOTUMOR CEREBRI; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 70449380385     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03593.x     Document Type: Letter

References (2)

1. Ball, A.K., Sinclair, A.J., Curnow, S.J. et al. (2008) Elevated CSF leptin in idiopathic intracranial hypertension: evidence for hypothalamic leptin resistance? Clinical Endocrinology, 70, 863 869.
2. Friedman, D.I. Jacobson, D.M. (2002) Diagnostic criteria for idiopathic intracranial hypertension. Neurology, 59, 1492 1495.